查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618170

羊膜市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Amniotic Membrane Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球羊膜市場估值為 17 億美元，預計 2024 年至 2032 年複合年成長率為 7.9%。發育中的胎兒提供重要的營養和生長因子。分娩後，這種膜由於其促進癒合的再生特性而在各種醫療和手術中發揮作用。對再生醫學的日益關注預計將成為重要的成長動力。該領域旨在透過幹細胞療法、組織工程和生物材料等創新方法來恢復或替換受損的組織和器官。

羊膜在這些應用中的潛力正在獲得認可，這主要是因為它們獨特的特性。最近的研究強調了羊膜內關鍵生物活性分子的存在，增強了其在再生醫學中的作用。從產品類型來看，市場可分為凍存羊膜和凍乾羊膜。到 2032 年，冷凍保存領域預計將達到 17 億美元，這主要是由於其在多個醫學學科的廣泛應用。

在眼科領域，冷凍羊膜用於治療各種角膜缺陷，包括持續性上皮缺陷、潰瘍和化學燒傷。該應用程式有助於加速癒合，同時最大限度地減少發炎和疤痕。 2023 年，眼科領域引領市場，營收達 3.421 億美元。羊膜移植（AMT）在該領域用於治療多種眼表疾病。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 17億美元
預測值 32億美元
複合年成長率 7.9%

羊膜是胎盤的最內層，具有多種益處，例如透過其膠原蛋白成分支持上皮細胞生長、減少發炎、防止血管生成以及透過覆蓋敏感的神經末梢提供鎮痛作用。在美國，羊膜市場預計到 2032 年將達到 11 億美元。隨著技術的快速進步，對再生醫學的日益重視預計將推動市場的進一步擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 再生醫學需求不斷成長
      • 慢性傷口的發生率上升
      • 生物技術與組織工程的進步
      • 提高羊膜產品的認知度與接受度
    • 產業陷阱與挑戰
      • 羊膜產品保存期限有限
      • 嚴格的監理政策
  • 成長潛力分析
  • 監管環境
  • 報銷場景
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

  • 主要趨勢
  • 冷凍保存
  • 凍乾的

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

  • 主要趨勢
  • 手術傷口
  • 眼科
  • 幹細胞生物學
  • 再生醫學
  • 產前診斷
  • 骨科
  • 皮膚科
  • 整型手術
  • 牙科
  • 婦科

第 7 章：市場估計與預測：依最終用途，2018 年 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心 (ASC)
  • 專科診所
  • 研究和學術機構
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Amnio Technology, LLC
  • Applied Biologics LLC
  • BioTissue Holdings Inc.
  • Celularity Inc.
  • Corza Health, Inc.
  • Integra LifeSciences Holdings Corporation
  • MiMedx Group, Inc.
  • Organogenesis Holdings Inc.
  • Skye Biologics, Inc.
  • Smith & Nephew plc
簡介目錄
Product Code: 8336

The Global Amniotic Membrane Market was valued at USD 1.7 billion in 2023 and is projected to experience a CAGR of 7.9% from 2024 to 2032. The amniotic membrane is a delicate, flexible tissue that lines the amniotic sac during pregnancy, serving as a protective barrier for the developing fetus while supplying vital nutrients and growth factors. Following childbirth, this membrane finds utility in various medical treatments and surgeries due to its regenerative properties that promote healing. The increasing focus on regenerative medicine is expected to be a significant growth driver. This field aims to restore or replace damaged tissues and organs through innovative methods such as stem cell therapy, tissue engineering, and biomaterials.

Amniotic membranes are gaining recognition for their potential in these applications, primarily because of their distinctive properties. Recent studies have highlighted the presence of key bioactive molecules within the amniotic membrane, reinforcing its role in regenerative medicine. In terms of product types, the market can be categorized into cryopreserved and lyophilized amniotic membranes. The cryopreserved segment is anticipated to reach USD 1.7 billion by 2032, primarily due to its extensive application across multiple medical disciplines.

In ophthalmology, cryopreserved amniotic membranes are used to treat various corneal defects, including persistent epithelial defects, ulcers, and chemical burns. This application aids in accelerating healing while minimizing inflammation and scarring. The ophthalmology segment led the market in 2023, with revenues reaching USD 342.1 million. Amniotic membrane transplantation (AMT) is utilized in this field to manage several ocular surface disorders.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.7 Billion
Forecast Value$3.2 Billion
CAGR7.9%

The amniotic membrane, being the innermost layer of the placenta, provides various benefits, such as supporting epithelial cell growth through its collagen composition, reducing inflammation, preventing angiogenesis, and offering analgesic effects by covering sensitive nerve endings. In the United States, the amniotic membrane market is projected to reach USD 1.1 billion by 2032. This growth can be attributed to advanced healthcare facilities and key industry players. The rising emphasis on regenerative medicine, in line with rapid technological advancements, is expected to fuel further market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market segmentation
  • 1.2 Market definition
  • 1.3 Research design
  • 1.4 Market size estimates and calculations
  • 1.5 Key trends for market estimates
  • 1.6 Forecast model
  • 1.7 Primary research & validation
    • 1.7.1 Primary sources
    • 1.7.2 Data mining sources
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis, 2018 - 2032
  • 2.2 Product trends
  • 2.3 Application trends
  • 2.4 End-use trends
  • 2.5 Regional trends

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing demand for regenerative medicine
      • 3.2.1.2 Rising incidence of chronic wounds
      • 3.2.1.3 Advancements in biotechnology and tissue engineering
      • 3.2.1.4 Increasing awareness and acceptance of amniotic membrane products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited shelf life of amniotic membrane products
      • 3.2.2.2 Stringent regulatory polices
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By application
    • 3.3.3 By end-use
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cryopreserved
  • 5.3 Lyophilized

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Surgical wounds
  • 6.3 Ophthalmology
  • 6.4 Stem cell biology
  • 6.5 Regenerative medicine
  • 6.6 Prenatal diagnosis
  • 6.7 Orthopedics
  • 6.8 Dermatology
  • 6.9 Plastic surgery
  • 6.10 Dentistry
  • 6.11 Gynecology

Chapter 7 Market Estimates and Forecast, By End Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers (ASCs)
  • 7.4 Specialty clinics
  • 7.5 Research and academic institutes
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Amnio Technology, LLC
  • 9.2 Applied Biologics LLC
  • 9.3 BioTissue Holdings Inc.
  • 9.4 Celularity Inc.
  • 9.5 Corza Health, Inc.
  • 9.6 Integra LifeSciences Holdings Corporation
  • 9.7 MiMedx Group, Inc.
  • 9.8 Organogenesis Holdings Inc.
  • 9.9 Skye Biologics, Inc.
  • 9.10 Smith & Nephew plc